A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | How to manage SE of OCPs | |||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||
3 | www.pandiahealth.com | |||||||||||||||||||||||||
4 | for lay people | https://www.pandiahealth.com/how-to-manage-birth-control-pill-side-effects/ | ||||||||||||||||||||||||
5 | for prescribers | https://www.pandiahealth.com/resources/birth-control-pill-side-effects-guide-for-providers/ | Based on web article by Frederick R. Jelovsek MD, MS | |||||||||||||||||||||||
6 | Progestin | Progestational Activity (relative to 1 mg of norethindrone) | Androgenic Activity (relative to 1 mg of norethindrone) | |||||||||||||||||||||||
7 | ||||||||||||||||||||||||||
8 | norethindrone 1 mg | 1.0 | 1.000 | etonogestrel | implant, nuvaring | less androgenic than levonorgestrel and norethisterone, | ||||||||||||||||||||
9 | norethindrone acetate 1 mg | 1.2 | 1.600 | norelgestromin | patch | active metabolites of norgestimate | BUT it produces levonorgestrel as an active metabolite to some extent | |||||||||||||||||||
10 | ethynodiol diacetate 1 mg | 1.4 | 0.600 | |||||||||||||||||||||||
11 | levonorgestrel 1 mg | 5.3 | 8.300 | |||||||||||||||||||||||
12 | dl-norgestrel 1 mg | 2.6 | 4.200 | |||||||||||||||||||||||
13 | norgestimate 1 mg | 1.3 | 1.900 | |||||||||||||||||||||||
14 | norelgestromin 1 mg | 1.3 | 1.900 | |||||||||||||||||||||||
15 | desogestrel 1 mg | 9.0 | 3.400 | |||||||||||||||||||||||
16 | drospirenone 1 mg | 1.5 | 0.000 | 3 mg of drosperinone = 20-25 mg of spironolactone in antimineralocorticoid effect | ||||||||||||||||||||||
17 | 1.95 | |||||||||||||||||||||||||
18 | CHART 2: from least androgenic to most | |||||||||||||||||||||||||
19 | Medication | progestin | mg of progestin | Androgenic activity | EE | progestational activity | ||||||||||||||||||||
20 | Slynd | drosperinone | 4.000 | 0.00 | - | 6 | ||||||||||||||||||||
21 | nextstellis | drosperinone | 3.000 | 0.00 | 0 | 3.9 | 14.2 mg of estetrol | 24 active, 4 placebo | ||||||||||||||||||
22 | Gianvi, Jasmiel, Loryna, Lo-Zumandimine, Nikki, Vestura, Yaz | drosperinone | 3.000 | 0.00 | 20 | 4.5 | ||||||||||||||||||||
23 | Ocella, Syeda, Yasmin, Zarah, Zumandimine | drosperinone | 3.000 | 0.00 | 30 | 4.5 | ||||||||||||||||||||
24 | Skyla 3 yrs | LNG | 0.014 | 0.07 | - | 0.12 | ||||||||||||||||||||
25 | Kyleena 5 yrs | LNG | 0.018 | 0.09 | - | 0.15 | Nexplanon | Once inserted subdermally, the release rate is 60-70 mcg/day in week 5-6 and decreases to approximately 35- 45 mcg/day at the end of the first year, to approximately 30-40 mcg/day at the end of the second year, and then to approximately 25-30 mcg/day at the end of the third year. | ||||||||||||||||||
26 | Nexplanon year 3 | etonogestrel | 0.040 | 0.14 | 0.36 | |||||||||||||||||||||
27 | Nexplanon year 2 | etonogestrel | 0.045 | 0.153 | 0.41 | |||||||||||||||||||||
28 | Liletta IUD Year 1 | levonorgestrel | 0.0186 | 0.154 | - | 0.099 | ||||||||||||||||||||
29 | Mirena IUD year 1 | LNG | 0.020 | 0.17 | - | 0.11 | Liletta/mirena start at 20mcg/day and down to 10mcg/day by year 5 | |||||||||||||||||||
30 | Nexplanon year 1 | etonogestrel | 0.060 | 0.20 | - | 0.54 | ||||||||||||||||||||
31 | Xulane | norelgestromin | 0.150 | 0.29 | 20 | 0.20 | May have diminished efficacy in women ≥90 kg = 198 lbs | |||||||||||||||||||
32 | Opill | norgestrel | 0.075 | 0.315 | 0 | 0.195 | POP | |||||||||||||||||||
33 | Camila 28, Deblitane, Errin, Heather, Jolivette, Jencycla, Lyza, Nora-BE, Norethindrone, Norlyda, POP, Sharobel, Ortho Micronor | norethindrone | 0.350 | 0.35 | -- | 0.35 | ||||||||||||||||||||
34 | Balziva, Briellyn, Femcon Fe, Gildagia, Philith, Ovcon 35, zenchent Fe, Zeosa, wymzya Fe | norethindrone | 0.400 | 0.40 | 35 | 0.4 | ||||||||||||||||||||
35 | NuvaRing | etonogestrel | 0.120 | 0.41 | 15 | 1.08 | ||||||||||||||||||||
36 | Estarylla, Norgestimate / Ethinyl Estradiol, Femynor, Mili, Mono-Linyah, Mononessa, Orthocyclen, Previfem, Sprintec, Vylibra, | norgestimate | 0.250 | 0.48 | 35 | 0.33 | ||||||||||||||||||||
37 | Brevicon; Modicon; Necon 0.5/35; Nelova 0.5/35; NEE 0.5/35 | norethindrone | 0.500 | 0.50 | 35 | 0.50 | ||||||||||||||||||||
38 | ortho novum 10/11, necon 10/11 [biphasic 0.5/35 and 1/35] | norethindrone | 0.500 | 0.50 | 35 | 0.50 | ||||||||||||||||||||
39 | Kariva, Kimidess, Mircette, Pimtrea, Viorele, Volnea, Mylan generic | desogestrel | 0.150 | 0.51 | 20 | 1.35 | 28 day desogestrel/ethinyl estradiol 0.15 mg/20 mcg tabs x21, then inert tabs x2, then 0 mg/10 mcg tabs x5 | |||||||||||||||||||
40 | Apri, Cyred, Desogen, Emoquette, Enskyce, Isibloom, Juleber, orthocept, Reclipsen, Solia | desogestrel | 0.150 | 0.51 | 30 | 1.35 | ||||||||||||||||||||
41 | Demulen, Zovia, Kelnor | ethynodiol diacetate | 1.000 | 0.60 | 35 | 1.4 | ||||||||||||||||||||
42 | ethinyl estradiol-ethynodiol 1/50 | ethynodiol diacetate | 1.000 | 0.60 | 50 | 1.4 | ||||||||||||||||||||
43 | Alyacen 7/7/7, Cyclafem 777, Dasetta 7/7/7, Nortrel 7/7/7, Necon 7/7/7, Ortho Novum 7/7/7, Pirmella 7/7/7, | norethindrone | 0.750 | 0.75 | 35 | 0.75 | 0.5, 0.75, 1 | |||||||||||||||||||
44 | Amethyst, (lybrel, discontinued) | LNG | 0.090 | 0.75 | 20 | 0.477 | 28 active pills | |||||||||||||||||||
45 | Alesse, Aubra, Aviane, Delyla, Larissia, Lessina, Levlite, Lutera, Orsythia, Sronyx, Vienva | LNG | 0.100 | 0.83 | 20 | 0.53 | 21 active tabs | european Microgynon 20 | ||||||||||||||||||
46 | Amethia Lo, CamreseLo, Lojaimiess, Loseasonique | LNG | 0.100 | 0.83 | 20 | 0.53 | 84 active tabs | 7 days of 10mcg EE | ||||||||||||||||||
47 | Aranelle, Leena, Tri-norinyl | norethindrone | 0.830 | 0.83 | 35 | 0.83 | 0.5, 1, 0.5 | |||||||||||||||||||
48 | Twirla | LNG | 0.120 | 0.996 | 30 | 0.64 | Contraindicated in women with BMI ≥30 kg/m2 due to decreased efficacy and increased risk of VTE. Diminished efficacy was observed in women with BMI ≥25 kg/m2. | |||||||||||||||||||
49 | Estrostep Fe, Tilia, Tril-egest | norethindrone | 1.000 | 1.00 | 20/30/35 | 1.00 | ||||||||||||||||||||
50 | Alyacen 1/35, Cyclafem, Dasetta, Necon 1/35; Nelova 1/35; NEE 1/35; Genora 1/35; Norcept-E 1/35; Nortrel 1/35, Genora 1/35; Norcept-E 1/35;Norethin 1/35E; Norinyl 1/35; Ortho-Novum 1/35 | norethindrone | 1.000 | 1.00 | 35 | 1.00 | ||||||||||||||||||||
51 | Necon 1/50, norinyl 1/50, orthonovum 1/50, ovcon 50 | norethindrone | 1.000 | 1.00 | 50 | 1.00 | ||||||||||||||||||||
52 | Altavera, Chateal, Levlen, Levora, Marlissa, Nordette, Portia, Iclevia, | LNG | 0.150 | 1.25 | 30 | 0.795 | european Microgynon 30 | |||||||||||||||||||
53 | Jolessa, Seasonale, Introvale, Quasense, Setlakin, Simpesse, Sylevia, Seasonique, Amethia, Ashlyna, Daysee, Camrese, Jaimiess | LNG | 0.150 | 1.25 | 30 | 0.795 | 84 active pills | seasonique has 7 days of 10 mcg EE at end | great list of seasonale generics and manufacturers: https://www.drugs.com/availability/generic-seasonale.html | |||||||||||||||||
54 | Cryselle, Lo Ovral, Low Ogestrel, elinest | norgestrel | 0.300 | 1.26 | 30 | 0.78 | ||||||||||||||||||||
55 | Lo Loestrin | norethindrone acetate | 1.000 | 1.60 | 10 | 1.2 | ||||||||||||||||||||
56 | Blisovi, Blisovi 24, Charlotte 24 Fe (chewable), Hailey 1/20, Gildess, Junel 1/20, Larin, Loestrin 1/20, Lomedia, Melodetta 24 Fe (chewable), Mibelas 24 Fe (chewable), Microgestin 1/20, Minastrin 24 Fe (chewable), Tarina, Taytulla (24/4) softgel | norethindrone acetate | 1.000 | 1.60 | 20 | 1.2 | ||||||||||||||||||||
57 | Ogestrel, generic Ovral | norgestrel | 0.500 | 2.1 | 50 | 1.3 | ||||||||||||||||||||
58 | Blisovi, Gildess, Junel 1.5/30, Larin, Loestrin 1.5/30, microgestin 1.5/30 | norethindrone acetate | 1.500 | 2.40 | 30 | 1.8 | ||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | * assumes progestin activity is the same as desogestrel | |||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | CHART 3 from least progestational activity to most | |||||||||||||||||||||||||
64 | Medication | progestin | mg of progestin | Androgenic activity | EE | progestational activity | ||||||||||||||||||||
65 | Skyla IUD | levonorgestrel | 0.0140 | 0.116 | - | 0.074 | ||||||||||||||||||||
66 | Kyleena IUD | levonorgestrel | 0.0175 | 0.145 | - | 0.093 | ||||||||||||||||||||
67 | Liletta IUD | levonorgestrel | 0.0186 | 0.154 | - | 0.099 | ||||||||||||||||||||
68 | Mirena IUD | levonorgestrel | 0.020 | 0.17 | - | 0.106 | ||||||||||||||||||||
69 | Opill | norgestrel | 0.075 | 0.315 | - | 0.195 | POP | |||||||||||||||||||
70 | Xulane | norelgestromin | 0.150 | 0.29 | 20 | 0.20 | ||||||||||||||||||||
71 | POP | norethindrone | 0.350 | 0.35 | - | 0.35 | ||||||||||||||||||||
72 | Estarylla, Orthocyclen, sprintec, Mono-Linyah, Previfem, Estarylla, Norgestimate / Ethinyl Estradiol, Femynor, Mononessa, Sprintec, Mili | norgestimate | 0.250 | 0.48 | 35 | 0.325 | Tri-Lo Marzia, Tri-Lo-Mili, Tri-Lo Estarylla, Trinessa LO, Tri-Lo Sprintec | 25 mcg EE | norgestimate/ethinyl estradiol 0.18 mg/25 mcg tab x7, then 0.215 mg/25 mcg tab x7, then 0.25 mg/25 mcg tab x7, then inert tab x7 | |||||||||||||||||
73 | Camila 28, Deblitane, Errin, Heather, Jolivette, Jencycla, Lyza, Nora-BE, Norethindrone, Norlyda, POP, Sharobel, Ortho Micronor | norethindrone | 0.350 | 0.35 | -- | 0.35 | ||||||||||||||||||||
74 | Nexplanon year 3 | etonogestrel | 0.040 | 0.14 | -- | 0.36 | ||||||||||||||||||||
75 | Balzivia, Briellyn, Gildagia, philith, Ovcon 35 | norethindrone | 0.400 | 0.40 | 35 | 0.40 | ||||||||||||||||||||
76 | Brevicon; Modicon; Necon 0.5/35; Nelova 0.5/35; NEE 0.5/35 | norethindrone | 0.500 | 0.50 | 35 | 0.50 | ||||||||||||||||||||
77 | ortho novum 10/11, necon 10/11 [biphasic 0.5/35 and 1/35] | norethindrone | 0.500 | 0.50 | 35 | 0.50 | ||||||||||||||||||||
78 | Aviane, Levlite, Lutera, Alesse(off market) Camrese Lo/ Loseasonique | LNG | 0.100 | 0.83 | 20 | 0.53 | ||||||||||||||||||||
79 | Twirla | LNG | 0.120 | 0.996 | 30 | 0.64 | Contraindicated in women with BMI ≥30 kg/m2 due to decreased efficacy and increased risk of VTE. Diminished efficacy was observed in women with BMI ≥25 kg/m2. | |||||||||||||||||||
80 | Cyclafem 777, Pirmella 7/7/7, Dasetta 7/7/7, Alyacen 7/7/7, Nortrel 7/7/7, Necon 7/7/7 | norethindrone | 0.750 | 0.75 | 35 | 0.75 | 0.5, 0.75, 1 | |||||||||||||||||||
81 | Lo Ovral, Low Ogestrel | norgestrel | 0.300 | 1.26 | 30 | 0.78 | ||||||||||||||||||||
82 | Altavera, Chateal, Jolessa, Kurvelo, Levlen, Levora, Lillow, Marlissa, Nordette, Portia,,, | LNG | 0.150 | 1.25 | 30 | 0.795 | ||||||||||||||||||||
83 | Seasonale, Iclevia, INtrovale, Quasense, Setlakin, Sylevia | LNG | 0.150 | 1.25 | 30 | 0.795 | ||||||||||||||||||||
84 | Seasonique, Amethia, Ashlyna, Camrese, Daysee, Jaimiess, Simpesse | LNG | 0.150 | 1.25 | 30 | 0.795 | seasonique has 10 mcg of EE placebo | simpesse = seasonique = Daysee, Ashlyna, Jaimiess, Camrese. | ||||||||||||||||||
85 | Aranelle, Leena, Tri-norinyl | norethindrone | 0.830 | 0.83 | 35 | 0.83 | 0.5, 1, 0.5 | |||||||||||||||||||
86 | Cyclafem, Dasetta, Necon 1/35; Nelova 1/35; NEE 1/35; Genora 1/35; Norcept-E 1/35; Nortrel, Genora 1/35; Norcept-E 1/35;Norethin 1/35E; Norinyl 1/35; Ortho-Novum 1/35 | norethindrone | 1.000 | 1.00 | 35 | 1.00 | ||||||||||||||||||||
87 | Necon 1/50, norinyl 1/50, orthonovum 1/50, ovcon 50 | norethindrone | 1.000 | 1.00 | 50 | 1.00 | ||||||||||||||||||||
88 | NuvaRing | etonogestrel* | 0.120 | 0.41 | 15 | 1.08 | ||||||||||||||||||||
89 | Lo Loestrin | norethindrone acetate | 1.000 | 1.60 | 10 | 1.2 | ||||||||||||||||||||
90 | Blisovi, Gildess, Junel 1/20, Junel Fe 24, Larin, Loestrin 1/20, Microgestin 1/20 | norethindrone acetate | 1.000 | 1.60 | 20 | 1.2 | Junel Fe 24 and similar is 20mcg EE + 4 days of 75 mg ferrous fumarate | |||||||||||||||||||
91 | Ogestrel, generic Ovral | norgestrel | 0.500 | 2.1 | 50 | 1.3 | ||||||||||||||||||||
92 | Kariva, Mircette, Viorele | desogestrel | 0.150 | 0.51 | 20 | 1.35 | ||||||||||||||||||||
93 | Apri, Desogen, Emoquette, Enskyce, orthocept, Reclipsen | desogestrel | 0.150 | 0.51 | 30 | 1.35 | ||||||||||||||||||||
94 | Demulen, Zovia, kelnor | ethynodiol diacetate | 1.000 | 0.60 | 35 | 1.4 | ||||||||||||||||||||
95 | Blisovi, Gildess, Junel 1.5/30, Larin, Loestrin 1.5/30, microgestin 1.5/30 | norethindrone acetate | 1.500 | 2.40 | 30 | 1.8 | ||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | Gianvi, Jasmiel, Loryna, Lo-Zumandimine, Nikki, Vestura, Yaz | drosperinone | 3.000 | 0.00 | 20 | 4.5 | In patients with conditions requiring chronic therapy with medications that may increase potassium, monitor serum potassium during the first treatment cycle and periodically thereafter if patient begins medication or develops a condition that increases risk for hyperkalemia. | |||||||||||||||||||
98 | Ocella, Syeda, Yasmin, Zarah, Zumandimine | drosperinone | 3.000 | 0.00 | 30 | 4.5 | ||||||||||||||||||||
99 | nextstellis | drosperinone | 3.000 | 0.00 | 0 | 4.5 | 14.2 mg of estetrol | 24 active, 4 placebo | ||||||||||||||||||
100 | Slynd | drosperinone | 4.000 | 0.00 | - | 6 | 24 active 4 placebo |